Neuroendocrine Tumor Treatment Market, By Therapy Type (Somatostatin Analog Therapy, Peptide Receptor Radionuclide Therapy (PRRT), Targeted Therapy and Chemotherapy), By Drug Class, By Tumor Type, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
REPORT HIGHLIGHT
Neuroendocrine Tumor Treatment Market size was valued at USD 2,510.21 Million in 2023, expanding at a CAGR of 9.10% from 2024 to 2032.
The Neur...
Report ID: AV2933
Publish date: 2024-12-09
Pages: 387
$3250
Lung Adenocarcinoma Treatment Market, By Drug Class (EGFR Inhibitors, ALK Inhibitors, PD-1/PD-L1 Inhibitors and VEGF Inhibitors), By Therapy Type, By Stage of Treatment, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
REPORT HIGHLIGHT
Lung Adenocarcinoma Treatment Market size was valued at USD 5,512.09 Million in 2023, expanding at a CAGR of 10.70% from 2024 to 2032.
The Lung...
Report ID: AV2932
Publish date: 2024-12-09
Pages: 395
$3250
Liver Cancer Drug Market, By Drug Class (VEGF Inhibitors, PD-1/PD-L1 Inhibitors and Tyrosine Kinase Inhibitors (TKIs)), By Therapy Type, By Route of Administration, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
REPORT HIGHLIGHT
Liver Cancer Drug Market size was valued at USD 3,151.90 Million in 2023, expanding at a CAGR of 17.82% from 2024 to 2032.
The Liver Cancer Dru...
Report ID: AV2931
Publish date: 2024-12-09
Pages: 377
$3250
Immunotoxins Market, By Type (Recombinant Immunotoxins, Chimeric Antigen Receptor (CAR) T-Cell Therapy and Monoclonal Antibody-Based Immunotoxins), By Delivery Method, By Target Indication, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
REPORT HIGHLIGHT
Immunotoxins Market size was valued at USD 142.90 Million in 2023, expanding at a CAGR of 8.90% from 2024 to 2032.
The Immunotoxins market, whi...
Report ID: AV2929
Publish date: 2024-12-09
Pages: 385
$3250
Hairy Cell Leukemia Treatment Market, By Drug Class (Purine Analogues, BRAF Inhibitors and CD20 Monoclonal Antibodies), By Therapy Type, By Route of Administration, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
REPORT HIGHLIGHT
Hairy Cell Leukemia Treatment Market size was valued at USD 102.90 Million in 2023, expanding at a CAGR of 5.40% from 2024 to 2032.
The Hairy C...
Report ID: AV2926
Publish date: 2024-12-09
Pages: 378
$3250
Genomics in Cancer Care Market, By Test Type (Germline Genomics Testing and Somatic Genomics Testing), By Technology Type, By Application, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
REPORT HIGHLIGHT
Genomics in Cancer Care Market size was valued at USD 18,120.32 Million in 2023, expanding at a CAGR of 16.10% from 2024 to 2032.
The Genomics...
Report ID: AV2925
Publish date: 2024-12-09
Pages: 387
$3250
Estrogen Receptor Positive Breast Cancer Treatment Market, By Drug Class (Selective Estrogen Receptor Modulators (SERMs), Aromatase Inhibitors, Cyclin-Dependent Kinase (CDK) Inhibitors and PI3K Inhibitors), By Therapy Type, By Route of Administration, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
REPORT HIGHLIGHT
Estrogen Receptor Positive Breast Cancer Treatment Market size was valued at USD 19,810.32 Million in 2023, expanding at a CAGR of 7.90% from 2024 to 203...
Report ID: AV2923
Publish date: 2024-12-09
Pages: 394
$3250
Common-mode Chokes Market, By Type (Power Line Chokes, Signal Line Chokes and Surface Mount Chokes), By Core Material, By Application, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
REPORT HIGHLIGHT
Common-mode Chokes Market size was valued at USD 629.97 Million in 2023, expanding at a CAGR of 5.49% from 2024 to 2032.
The Common-mode Chokes...
Report ID: AV2921
Publish date: 2024-12-09
Pages: 389
$3250
Cancer Supportive Care Drugs Market, By Drug Type (Erythropoiesis-Stimulating Agents, Granulocyte Colony-Stimulating Factors (G-CSFs), Anti-emetics and Bisphosphonates), By Therapeutic Area, By Distribution, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
REPORT HIGHLIGHT
Cancer Supportive Care Drugs Market size was valued at USD 21,410.32 Million in 2023, expanding at a CAGR of 2.31% from 2024 to 2032.
The Cance...
Report ID: AV2920
Publish date: 2024-12-09
Pages: 378
$3250
Cancer Biomarkers Market, By Biomarker Type (Genetic Biomarkers, Protein Biomarkers, Epigenetic Biomarkers and Metabolic Biomarkers), By Cancer Type, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
REPORT HIGHLIGHT
Cancer Biomarkers Market size was valued at USD 28,928.41 million in 2023, expanding at a CAGR of 12.90% from 2024 to 2032.
The Cancer Biomarke...